EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.5.1.86 | Carcinoma, Hepatocellular |
25780306 |
Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
2
0 |
| 2.5.1.86 | Hypersensitivity |
14519123 |
Fission yeast decaprenyl diphosphate synthase consists of Dps1 and the newly characterized Dlp1 protein in a novel heterotetrameric structure. |
unassigned |
0 |
| 2.5.1.86 | Leigh Disease |
17186472 |
Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.5.1.86 | Neoplasm Metastasis |
34408002 |
PDSS1-mediated activation of CAMK2A-STAT3 signaling promotes metastasis in triple-negative breast cancer. |
unassigned |
0 |
| 2.5.1.86 | Nephrotic Syndrome |
17186472 |
Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.5.1.86 | Stomach Neoplasms |
34377022 |
Propofol Suppresses Gastric Cancer Progression by Regulating circPDSS1/miR-1324/SOX4 Axis. |
unassigned |
0 |
| 2.5.1.86 | Tuberculosis |
15516568 |
Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis. |
unassigned |
0 |
| 2.5.1.86 | Tuberculosis |
18597781 |
The structural basis of chain length control in Rv1086. |
unassigned |
0 |
| 2.5.1.86 | Tuberculosis |
24475925 |
Structure and inhibition of tuberculosinol synthase and decaprenyl diphosphate synthase from Mycobacterium tuberculosis. |
ongoing research
therapeutic application
unassigned |
4
2
0 |
| 2.5.1.86 | Tuberculosis |
29268770 |
Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis. |
diagnostic usage
unassigned |
3
0 |
